Immunespec (2023): advanced immunopeptidomics for fast & reliable immunogenic profiling

Immunespec uses advanced immunopeptidomics for fast & reliable immunogenic profiling. Thanks to this renewed approach to unlock immunogenic regions of proteins they contribute to the development of safe, effective vccines and therapeutics.
Football college (2022): research on good governance of football and practical education

Football College conducts and disseminates research on good governance of football. It offers educational programmes and events that are both academically underpinned and practically oriented, in addition to ad hoc advice.
IoSA (2022): animal behavior monitoring tool

IoSA combines the expertise of engineers of imec-IDlab and ecologists of UAntwerp to create logging tools, focusing on highly accurate proximity tracking and ultra-low power data processing. While traditional trackers are rather bulky and heavy, IoSA was able to pack these features in ultra-light miniaturized solutions, weighing no more than 5 percent of the animal’s body weight. IoSA’s solutions will provide new valuable insights to researchers, wildlife and conservation organizations, zoos, and farmers on how animals interact and move.
Optanic (2022): plasma technology for dry reforming of methane into syngas and methanol
Optanic aims to to scale up plasma technology for dry reforming of methane into syngas and methanol, and build larger (atmospheric pressure glow discharge) plasma reactors, of interest for biogas valorization, and producing value-added chemicals from it
Innocens (2022): AI based Clinical Decision Support System for Neonatal Intensive Care

Innocens is a spin-off company from the University Hospital Antwerp/University Antwerp founded. Their vision is to improve care by providing healthcare workers explainable insights on their growing landscape of available clinical data. Innocens developed an AI based Clinical Decision Support System for Neonatal Intensive Care that keeps the healtcare worker in the lead of her/his decision. The digital health worker provides a 24/7 risk prediction and explains its reasoning. The technology is privacy compliant and scalable to different intensive care settings. Innocens technology improves your clinical insights and enriches your data to create a continuous improving environment. The vision of Innocens is to aid decision-making of healthcare workers taking care of vulnerable infants. Together we create value to what all of us consider most valuable in our life!
AdaptEm (2022): fully programmable phase plates for electron microscopes

AdaptEM is a company providing fully programmable phase plates for electron microscopes. Our patented technology is based on individual Einzel lens controlling each of the 48 independent pixels forming the phase plate. Each pixel can apply a constant phase shift to the coherent electron wave front giving unprecedent control over the quantum wavefunction of the electron beam. Applications include but are not limited to formation of exotic beam shapes, adaptive aberration correction, contrast enhancement, symmetry selection in inelastic scattering, solution of inverse scattering problems, determination of chiral structures, seeing through thick samples, depth sectioning, increased depth of focus, and many more!
DT Valley (2021): developing and optimizing mechatronic systems

DT Valley supports and/or guides R&D teams in developing or optimizing mechatronic systems. They focus in particular on the design processes involved. In this context they also provide our own EPSim tool. A virtual platform for integrated systems, developed in cooperation with the University of Antwerp and Flanders Make. This allows testing much earlier in the design process.
ImmuneWatch (2021): Determines the target of T-cell receptors

Immunewatch is a Belgium based spin-off of the University of Antwerp and the Antwerp University Hospital, aiming to accelerate the development of vaccines and therapies by making immune repertoire data interpretable and clinically actionable. Using bio-informatics and artificial intelligence, Immunewatch determines the target of T-cell receptors (TCR), leading to improved prediction and monitoring of the immune response. By sequencing and analyzing the TCR repertoire, the team provides their customers with a better understanding of T-cell responses in the fields of infectious diseases, oncology and auto-immunity.
Oxylum (2021): Solutions for the sustainable production of chemicals

Oxylum is a Belgian based, University of Antwerp spin-off company who focusses on the development of solutions for the sustainable production of chemicals. Their novel electrochemical CO₂ reduction technology will guide companies in their quest towards carbon neutrality. Similarly to the leaves of a tree, they use CO₂ and water to create the building blocks for plastics, fuels and so much more. The required energy is provided by renewable electricity and no fossil feedstocks are consumed during the process.
A-membranes (2021): Membrane technology

A-membranes develops and produces bespoke organically grafted ceramic membranes. The ‘A-membranes’ combine high stability with tunable chemical affinity and allow for tailor-made filtration solutions both in solvent and aqueous environments.
Purna Female Healthcare (2021): Innovative combination therapy for the treatment of vulvovaginal candidiasis

Purna Female Healthcare (“PFH”) develops and commercialises an innovative combination therapy for the treatment of severe and recurrent vulvovaginal candidiasis (rVVC). It is a spin-off founded by Purna Pharmaceuticals NV and Creafund NV in partnership with Hyloris Pharmaceuticals. PFH has exclusively in-licensed antifungal Miconazole with Domiphen Bromide (MCZ-DB) and associated IP owned by the University of Antwerp and KU Leuven.
D-CRBN (2021): CO2 conversion technology

D-CRBN, a spin-off company from the University of Antwerp has developed a cutting edge technology that enables the conversion of CO2. This innovative process uses plasma to split CO2 molecules into its original building blocks. These building blocks can be re-used to create valuable products such as biofuels, chemicals, or polymers to ultimately achieve a circular and more sustainable economy.
Amber Therapeutics (2020): Developing intelligent bioelectrical therapies

Amber’s first therapy will bring adaptive stimulation technology to the established neuromodulation approach for treating urinary incontinence, with the promise of radically improving clinical outcomes.
Garvis (2020): Forecasting solution for planners

Garvis is a bionic forecasting solution that combines transparent artificial intelligence with the insights of the planner for real-time data analysis. This allows to reduce the forecast error with 30% and allows enterprises to provide a better service with less time and less stock. Garvis has a big impact on the bottom line of an enterprise and can be implemented in less than 24 hours.
LinkedCar (2020): Mobility technology

Would you like to predict when your car tires need replacement? Or extract data from your e-bike using your smartphone? Sounds like sci-fi? But it isn’t! LinkedCar platform, the first spin-off of Karel de Grote University of Applied Sciences and Arts, accomplishes all of this. LinkedCar uses the data from your vehicle as a connector between you and your mobility partners such as insurance companies, lease managers and roadside technicians.
Medimundi (2020): Respirators with increased comfort for the wearer

The company designs and produces high quality, comfortable FFP2 and FFP3 respirators, and other personal protective equipment is the facility in Belgium.
Crowdscan (2020): A wireless crowd density system

Deltaray (2019): 3D Xray-technology
Shavatar (2019): Technology generates 3D body shape
Anicells (2019): innovative cell therapy solutions to the patient

Anicells, a spin-off of the University of Antwerp and the Antwerp University Hospital, is built on the expertise of people specialized in clinical development and manufacturing of cell therapy products. Anicells facilitates and guides the go-to-patient strategy of cell therapy developers by offering regulatory support, development-on-demand, and GMP-compliant manufacturing of cell-based investigational medicinal products. The facilities have multiple sterile cell-processing cleanrooms with classification B and C, including cell-purification devices as well as a QC lab.
DigiTrans (2019): Data-driven logistics solution for the transport sector
www.digitrans.io
Comproved (ex-D-PAC) (2018): Comparative judgments for assessments
Aloxy (2017): Industrial Internet of Things
iFlux (2017): Measurements soil contamination
Epilog (2017): EEG diagnostic technology

Fluent.ai (2017): Speech interface solution

Froomle (2016): Software based on data science
Elmedix (2016): Medical devices
TextGain (2015): Automatic text analytics
Predicube (2014): Big data technology
CareerCoach (2014): Career management tools
Hysopt (2014): Simulation technology HVAC
CiBLiS (2013): Library software

Ciblis develops and distributes globally web based library software. It is a spin-off of the ICT intermunicipal association CIPAL with also UAntwerpen – the original developer of the software – and LRM as shareholder.
The Brocade software is used by academic, public and specialized libraries, but also documentation centers, archives and musea. Different libraries are able to collaborate in networks thanks to the ‘cloud’-framework. Ciblis has many installations in Belgium and the Netherlands and is even leader in South-Africa with more than 900 implemented libraries.
Novosanis (2013): Medical devices
Status: exit
BrightSpec (2012): Nuclear and X-ray instrumentation
Valita Technology (2012): Smart caring concepts
Oxypoint (2011): Optimisation oxygen consumption
icoMetrix (2011): Imaging techniques and analysis methods
Normalized Systems Venture (2011): Software architecture

NSX is a consultancy company focused on the implementation of Normalized Systems in industrial environments. The increasing architectural complexity and size of software results in an ever increasing test and analysis time when new functionality is added to existing software. Normalized Systems Theory aims at reducing this time, its associated cost and reduced usability by creating evolvable software architecture for enterprise IT systems.
ADxNeurosciences (2011): Diagnose optimisation
ADx provides state-of-the-art technologies, broad expertise in medical diagnostics, performance improvement and solutions for delivering more accurate and indispensable tools at a lower cost. The ADx team has been the driving force behind the development, market introduction and commercialization of the most widely used CSF marker assays, which are directly related to the key hallmarks of Alzheimer’s disease.
HI10 (2010): Data security and cloud systems architecture
Multiplicom (2010): Genetic test kits

Multiplicom, founded in 2010, is a spin-off of the University of Antwerp and VIB. The company develops, manufactures and commercializes leading-edge and easy-to-use genetic test kits based on the latest molecular diagnostic technologies. Multiplicom’s diagnostic products enable medical genetics and clinical laboratories to meet an increasing demand for molecular diagnostic testing, driven by the scientific evidence that links genetic information to health and disease.
Status: exit
AtSharp (2010): Localisation technology
Status: exit in 2018.
Viloc (2010): Equipment management and object security
Meshbone (2009): Wireless networking technology
Status: exit
TRI-VIZOR (2008): Orchestrator for transport and logistics
1-OK (2008): Electronic wallets
Status: exit.
Octens (2007): ISE-technology
Status: liquidation.
Mu Technologies (2007): Sound modeling and analysis
Nesma Consult (2006): Consulting (diversity, gender, ...)
Textkernel (2005): Recruitment technology
Status: exit.
FluidDA (2005): FRI technology
DCILabs (2001): High Content Screening
Status: exit.
HistoGenex (2001): Histopathological techniques